AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 6 analysts
Fundamentals
Fundamentals institutional score is 56 using growth durability 56.1.
Valuation
Valuation institutional score is 64 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 5 using mean target upside -13.8%; dispersion penalty 17.0; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 52 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is skewing constructive on impact and recency. Based on 1 recent ticker-linked news items.
Signal Summary
Market intelligence remains Mixed. market sentiment provide support, while analyst consensus and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 0.5% above historical median. Valuation is declining — currently in the undervalued zone (z-score: -0.03). Confidence: 77%.
Live forward EPS implies next-12-month EPS of ₹47.93. Applying the stock's normalized valuation corridor produces a fair range of ₹2,358.16 to ₹3,414.05, with base value near ₹2,864.30 (+53.7% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹47.93
Forward P/E
38.9x
Base Fair Value
₹2,864.30
Fair Range
₹2,358.16 - ₹3,414.05
Upside To Base
+53.7%
Estimate Source
Live forward EPS
Growth Estimate
-7.5%
5Y Average
48.60
Current
60.09
Overvalued
71.23
Undervalued
49.20
5Y Average
7.68
Current
9.50
Overvalued
9.86
Undervalued
4.82
5Y Average
6.34
Current
6.08
Overvalued
7.14
Undervalued
5.28
Peers & Comparison
Sector: Materials · Theme: Packaging
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
EPL LIMITED EPLPackaging | +17.7% | 8.2% | 19.4x Fair | 0% vs avg | -1.0% |
POLY MEDICURE LIMITED trades at a premium (60.1x vs peer avg 19.4x), implying higher growth or quality expectations from the Packaging cohort. Peers include EPL LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹431 CrJun 2026Latest net profit
₹88 CrJun 2026Latest EPS
₹8.69Jun 2026Net margin
28.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 306 | 320 | 321 | 361 | 367 | 402 | 411 | 421 | 384 | 417 | 419 | 443 | 431 |
| Expenses + | 220 | 237 | 236 | 264 | 266 | 290 | 295 | 305 | 283 | 305 | 307 | 322 | 310 |
| Operating Profit | 85 | 83 | 84 | 97 | 101 | 113 | 115 | 116 | 101 | 111 | 112 | 121 | 121 |
| OPM % | 28% | 26% | 26% | 27% | 28% | 28% | 28% | 28% | 26% | 27% | 27% | 27% | 28% |
| Other Income + | 13 | 13 | 17 | 16 | 17 | 27 | 22 | 24 | 42 | 34 | 23 | 15 | 29 |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 4 | 4 |
| Depreciation | 15 | 15 | 16 | 16 | 19 | 20 | 21 | 21 | 23 | 24 | 25 | 26 | 26 |
| Profit before tax | 81 | 78 | 82 | 94 | 96 | 117 | 113 | 116 | 117 | 118 | 106 | 107 | 119 |
| Tax % | 25% | 24% | 25% | 25% | 25% | 25% | 25% | 26% | 25% | 25% | 26% | 25% | 26% |
| Net Profit + | 61 | 59 | 61 | 71 | 72 | 87 | 85 | 87 | 88 | 89 | 78 | 81 | 88 |
| EPS in Rs | 6.31 | 6.17 | 6.41 | 7.35 | 7.53 | 8.61 | 8.40 | 8.55 | 8.68 | 8.79 | 7.73 | 7.95 | 8.69 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Statement Of Deviation & Variation For The Quarter Ended 30Th June, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency Report